| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |